Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 23, 2020

SELL
$89.56 - $126.72 $2,597 - $3,674
-29 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$68.28 - $123.65 $1,980 - $3,585
29 New
29 $3,000
Q2 2019

Jul 23, 2019

SELL
$107.38 - $129.34 $3,006 - $3,621
-28 Closed
0 $0
Q1 2019

May 09, 2019

BUY
$105.93 - $142.47 $2,966 - $3,989
28 New
28 $4,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.89B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Macroview Investment Management LLC Portfolio

Follow Macroview Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Macroview Investment Management LLC with notifications on news.